MR coronary angiography with SH L 643 A: Initial experience in patients with coronary artery disease

Radiology

Volumn 233, Issue 2, 2004, Pages 567-573

  Herborn, Christoph U ^a   Schmidt, Michaela ^b   Bruder, Oliver ^c   Nagel, Eike ^d   Shamsi, Kohkan ^e   Barkhausen, Jörg ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b SIEMENS AG   (Germany)

^c ELISABETH KRANKENHAUS ESSEN   (Germany)

^d DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^e BAYER PHARMA AG   (Germany)

Author keywords

Arteries, stenosis or obstruction, 548.762, 548.763; Coronary vessels, MR, 548.121413, 548.121416, 548.121419, 548.12142, 548.12143; Magnetic resonance (MR), contrast media; Magnetic resonance (MR), vascular studies

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; GADOMER 17;

ACCURACY; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BREATH HOLDING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; IMAGE QUALITY; IMAGING SYSTEM; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RIGHT CORONARY ARTERY; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; STATISTICAL SIGNIFICANCE; STUDENT T TEST; THREE DIMENSIONAL IMAGING;

AGED; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 7044235695     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2332031545     Document Type: Article

References (40)

1. American Heart Association. Heart and stroke statistics - 2003 update. Dallas, Tex: American Heart Association, 2002.
2. Judkins MP. Selective coronary arteriography. I. A percutaneous transfemoral technique. Radiology 1967; 89:815-824.
3. Sones FM. Acquired heart disease (abstr). Symposium on present and future of cineangiography. Am J Cardiol 1959; 3:710.
4. Karnegis JN, Heinz J. The risk of diagnostic cardiovascular catheterization. Am Heart J 1979; 97:291-297.
5. Gersh BJ, Kronmal RA, Frye RL, et al. Coronary arteriography and coronary artery bypass surgery: morbidity and mortality in patients ages 65 years or older - a report from the Coronary Artery Surgery Study. Circulation 1983; 67:483-491.
6. van Rossum AC, Bedaux WL, Hofman MB. Morphologic and functional evaluation of coronary artery bypass conduits. J Magn Reson Imaging 1999; 10:734-740.
7. Goldfarb JW, Edelman RR. Coronary arteries: breath-hold, gadolinium-enhanced, three-dimensional MR angiography. Radiology 1998; 206:830-834.
8. Zheng J, Li D, Bae KT, Woodard P, Haacke EM. Three-dimensional gadolinium-enhanced coronary magnetic resonance angiography: initial experience. J Cardiovasc Magn Reson 1999; 1:33-41.
9. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994; 191:155-164.
10. Kessler W, Laub G, Achenbach S, Ropers D, Moshage W, Daniel WG. Coronary arteries: MR angiography with fast contrast-enhanced three-dimensional breath-hold imaging - initial experience. Radiology 1999; 210:566-572.
11. Stillman AE, Wilke N, Li D, Haacke M, McLachlan S. Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: studies in human patients. J Comput Assist Tomogr 1996; 20:51-55.
12. Engelbrecht MR, Saeed M, Wendland MF, Canet E, Oksendal AN, Higgins CB. Contrast-enhanced 3D-TOF MRA of peripheral vessels: intiavascular versus extracellular MR contrast media. J Magn Reson Imaging 1998; 8:616-621.
13. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998; 207:529-538.
14. Taylor AM, Panting JR, Keegan J, et al. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography. J Magn Reson Imaging 1999; 9:220-227.
15. Li D, Dolan RP, Walovitch RC, Lauffer RB. Three-dimensional MRI of coronary arteries using an intravascular contrast agent. Magn Reson Med 1998; 39:1014-1018.
16. Johansson LO, Nolan MM, Taniuchi M, Fischer SE, Wickline SA, Lorenz CH. High-resolution magnetic resonance coronary angiography of the entire heart using a new blood-pool agent, NC100150 injection: comparison with invasive x-ray angiography in pigs. J Cardiovasc Magn Reson 1999; 1:139-143.
17. Stuber M, Botnar RM, Danias PG, et al. Contrast agent-enhanced, free-breathing, three-dimensional coronary magnetic resonance angiography. J Magn Reson Imaging 1999; 10:790-799.
18. Klein C, Nagel E, Schnackenburg B, et al. The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease. MAGMA 2000; 11:65-67.
19. Li D, Zheng J, Weinmann HJ. Contrast-enhanced MR imaging of coronary arteries: comparison of intra- and extravascular contrast agents in swine. Radiology 2001; 218:670-678.
20. Herborn CU, Barkhausen J, Paetsch I, et al. Coronary arteries: contrast-enhanced MR imaging with SH L 643A - experience in 12 volunteers. Radiology 2003; 229:217-223.
21. Tombach B, Reimer P, Mahler M, Ebert W, Shamsi K, Heindel W. First pass and blood pool effect of a new gadolinium-containing MR contrast agent: phase I clinical trial of Gadomer-17 (abstr). In: Proceedings of the 10th Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2002; 2585.
22. Scheffler K, Hennig J. T(1) quantification with inversion recovery TrueFISP. Magn Reson Med 2001; 45:720-723.
23. van der Zwet PM, Reiber JH. A new approach for the quantification of complex lesion morphology: the gradient field transform - basic principles and validation results. J Am Coll Cardiol 1994; 24:216-224.
24. Brittain JH, Hu BS, Wright GA, Meyer CH, Macovski A, Nishimura DG. Coronary angiography with magnetization-prepared T2 contrast. Magn Reson Med 1995; 33:689-696.
25. Bornar RM, Stuber M, Danias PG, Kissinger KV, Manning WJ. Improved coronary artery definition with T2-weighted, free-breathing, three-dimensional coronary MRA. Circulation 1999; 99:3139-3148.
26. Stuber M, Botnar RM, Danias PG, et al. Double-oblique free-breathing high resolution thiee-dimensional coronary magnetic resonance angiography. J Am Coll Cardiol 1999; 34:524-531.
27. Li D, Paschal CB, Haacke EM, Adler LP. Coronary arteries: three-dimensional MR imaging with fat saturation and magnetization transfer contrast. Radiology 1993; 187:401-406.
28. Wielopolski PA, van Geuns RJ, de Feyter PJ, Oudkerk M. Breath-hold coronary MR angiography with volume-targeted imaging. Radiology 1998; 209:209-219.
29. Li D, Carr JC, Shea SM, et al. Coronary arteries: magnetization-prepared contrast-enhanced three-dimensional volume-targeted breath-hold MR angiography. Radiology 2001; 219:270-277.
30. Barkhausen J, Hunold P, Jochims M, et al. Comparison of gradient-echo and steady state free precession sequences for 3D-navigator MR angiography of coronary arteries. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002; 174:725-730. [German]
31. Deshpande VS, Shea SM, Chung YC, McCarthy RM, Finn JP, Li D. Breath-hold three-dimensional true-FISP imaging of coronary arteries using asymmetric sampling. J Magn Reson Imaging 2002; 15:473-478.
32. Gerber BL, Bluemke DA, Chin BB, et al. Single-vessel coronary artery stenosis: myocardial perfusion imaging with Gadomer-17 first-pass MR imaging in a swine model of comparison with gadopentetate dimeglumine. Radiology 2002; 225:104-112.
33. Huber ME, Paetsch I, Schnackenburg B, et al. Performance of a new gadolinium-based intravascular contrast agent in free-breathing inversion-recovery 3D coronary MRA. Magn Reson Med 2003; 49:115-121.
34. Taupitz M, Schnorr J, Wagner S, et al. Coronary magnetic resonance angiography: experimental evaluation of the new rapid clearance blood pool contrast medium P792. Magn Reson Med 2001; 46:932-938.
35. Bedaux WL, Hofman MB, Wielopolski PA, et al. Three-dimensional magnetic resonance coronary angiography using a new blood pool contrast agent: initial experience. J Cardiovasc Magn Reson 2002; 4:273-282.
36. Knollmann FD, Bock JC, Rautenberg K, Beier J, Ebert W, Felix R. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography: preliminary results of an animal study original investigation. Invest Radiol 1998; 33:637-643.
37. Taupitz M, Schnorr J, Wagner S, et al. Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium. Radiology 2002; 222:120-126.
38. Taupitz M, Schnorr J, Abramjuk C, et al. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits. J Magn Reson Imaging 2000; 12:905-911.
39. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001; 345:1863-1869.
40. Sommer T, Hofer U, Hackenbroch M, et al. Submillimeter 3D coronary MR angiography with real-time navigator correction in 107 patients with suspected coronary artery disease. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002; 174:459-466. [German]